Cargando…
Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions
Keratoconus is a disorder characterized by progressive corneal thinning and steepening that may result in significant visual impairment secondary to high astigmatism, corneal scarring, or even corneal perforation. Early detection and screening of keratoconus are essential for effective management an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511017/ https://www.ncbi.nlm.nih.gov/pubmed/37736107 http://dx.doi.org/10.2147/OPTH.S392665 |
_version_ | 1785108061766025216 |
---|---|
author | Bui, Anh D Truong, Angeline Pasricha, Neel D Indaram, Maanasa |
author_facet | Bui, Anh D Truong, Angeline Pasricha, Neel D Indaram, Maanasa |
author_sort | Bui, Anh D |
collection | PubMed |
description | Keratoconus is a disorder characterized by progressive corneal thinning and steepening that may result in significant visual impairment secondary to high astigmatism, corneal scarring, or even corneal perforation. Early detection and screening of keratoconus are essential for effective management and treatment. Several screening methods, such as corneal topography and tomography, corneal biomechanics, and genetic testing, are being developed to detect keratoconus at an early stage. Once detected, prevention of progression is the mainstay of keratoconus management. Corneal collagen cross-linking is a minimally invasive treatment option that can slow or halt the progression of keratoconus. Additionally, recent studies have investigated the potential use of copper sulfate eye drops (IVMED-80) and extracellular vesicles to prevent the progression of keratoconus as non-invasive treatment options. For visual rehabilitation, currently available treatments include scleral lenses, intracorneal ring segments, corneal allogenic intrastromal ring segments, and deep anterior lamellar keratoplasty. The safety and efficacy of these emerging treatment options for keratoconus are currently being investigated. |
format | Online Article Text |
id | pubmed-10511017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-105110172023-09-21 Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions Bui, Anh D Truong, Angeline Pasricha, Neel D Indaram, Maanasa Clin Ophthalmol Review Keratoconus is a disorder characterized by progressive corneal thinning and steepening that may result in significant visual impairment secondary to high astigmatism, corneal scarring, or even corneal perforation. Early detection and screening of keratoconus are essential for effective management and treatment. Several screening methods, such as corneal topography and tomography, corneal biomechanics, and genetic testing, are being developed to detect keratoconus at an early stage. Once detected, prevention of progression is the mainstay of keratoconus management. Corneal collagen cross-linking is a minimally invasive treatment option that can slow or halt the progression of keratoconus. Additionally, recent studies have investigated the potential use of copper sulfate eye drops (IVMED-80) and extracellular vesicles to prevent the progression of keratoconus as non-invasive treatment options. For visual rehabilitation, currently available treatments include scleral lenses, intracorneal ring segments, corneal allogenic intrastromal ring segments, and deep anterior lamellar keratoplasty. The safety and efficacy of these emerging treatment options for keratoconus are currently being investigated. Dove 2023-09-16 /pmc/articles/PMC10511017/ /pubmed/37736107 http://dx.doi.org/10.2147/OPTH.S392665 Text en © 2023 Bui et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Bui, Anh D Truong, Angeline Pasricha, Neel D Indaram, Maanasa Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title | Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title_full | Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title_fullStr | Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title_full_unstemmed | Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title_short | Keratoconus Diagnosis and Treatment: Recent Advances and Future Directions |
title_sort | keratoconus diagnosis and treatment: recent advances and future directions |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511017/ https://www.ncbi.nlm.nih.gov/pubmed/37736107 http://dx.doi.org/10.2147/OPTH.S392665 |
work_keys_str_mv | AT buianhd keratoconusdiagnosisandtreatmentrecentadvancesandfuturedirections AT truongangeline keratoconusdiagnosisandtreatmentrecentadvancesandfuturedirections AT pasrichaneeld keratoconusdiagnosisandtreatmentrecentadvancesandfuturedirections AT indarammaanasa keratoconusdiagnosisandtreatmentrecentadvancesandfuturedirections |